Healthcare provider profile · identity verified

Jane Koroma, MSN

Nurse Practitioner · COLUMBUS, OH · NPI 1477905461

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	531	213
Amlodipine Besylate	Amlodipine Besylate	382	168
Albuterol Sulfate Hfa	Albuterol Sulfate	364	142
Gabapentin	Gabapentin	347	139
Lisinopril	Lisinopril	329	140
Prednisone	Prednisone	320	149
Montelukast Sodium	Montelukast Sodium	271	121
Losartan Potassium	Losartan Potassium	249	104
Tizanidine Hcl	Tizanidine Hcl	241	114
Levothyroxine Sodium	Levothyroxine Sodium	210	78
Azithromycin	Azithromycin	183	96
Omeprazole	Omeprazole	177	73
Metoprolol Succinate	Metoprolol Succinate	171	66
Pantoprazole Sodium	Pantoprazole Sodium	167	78
Metformin Hcl	Metformin Hcl	160	76
Furosemide	Furosemide	149	86
Diclofenac Sodium	Diclofenac Sodium	148	95
Carvedilol	Carvedilol	141	68
Fluticasone Propionate	Fluticasone Propionate	138	93
Trazodone Hcl	Trazodone Hcl	123	59
Ibuprofen	Ibuprofen	115	78
Glipizide	Glipizide	111	52
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	107	51
Rosuvastatin Calcium	Rosuvastatin Calcium	103	43
Meloxicam	Meloxicam	99	56
Potassium Chloride	Potassium Chloride	87	43
Eliquis	Apixaban	77	28
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	76	61
Duloxetine Hcl	Duloxetine Hcl	76	36
Hydrochlorothiazide	Hydrochlorothiazide	76	31
Simvastatin	Simvastatin	75	28
Methylprednisolone	Methylprednisolone	73	62
Tamsulosin Hcl	Tamsulosin Hcl	72	36
Sertraline Hcl	Sertraline Hcl	69	35
Clopidogrel	Clopidogrel Bisulfate	68	41
Donepezil Hcl	Donepezil Hcl	68	25
Metoprolol Tartrate	Metoprolol Tartrate	68	26
Metformin Hcl Er	Metformin Hcl	67	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	25
Oxybutynin Chloride Er	Oxybutynin Chloride	60	30
Famotidine	Famotidine	59	33
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	59	15
Hydralazine Hcl	Hydralazine Hcl	58	21
Citalopram Hbr	Citalopram Hydrobromide	56	24
Allopurinol	Allopurinol	54	24
Alendronate Sodium	Alendronate Sodium	51	26
Buspirone Hcl	Buspirone Hcl	51	23
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	49	12
Venlafaxine Hcl	Venlafaxine Hcl	48	17
Hydroxyzine Hcl	Hydroxyzine Hcl	47	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	17
Nifedipine Er	Nifedipine	45	21
Venlafaxine Hcl Er	Venlafaxine Hcl	42	14
Torsemide	Torsemide	41	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	32
Naproxen	Naproxen	37	20
Ropinirole Hcl	Ropinirole Hcl	34	14
Spironolactone	Spironolactone	34	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	15
Ozempic	Semaglutide	32	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	32	11
Jardiance	Empagliflozin	31	suppressed
Atenolol	Atenolol	29	13
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	15
Roflumilast	Roflumilast	26	15
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	14
Mirtazapine	Mirtazapine	25	15
Quetiapine Fumarate	Quetiapine Fumarate	25	14
Spiriva Handihaler	Tiotropium Bromide	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	12
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Valsartan	Valsartan	22	11
Januvia	Sitagliptin Phosphate	21	suppressed
Ondansetron Odt	Ondansetron	21	15
Spiriva Respimat	Tiotropium Bromide	21	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	15
Varenicline Tartrate	Varenicline Tartrate	20	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	11
Loperamide	Loperamide Hcl	19	12
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	13
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	11
Cephalexin	Cephalexin	17	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	14
Methocarbamol	Methocarbamol	17	suppressed
Cilostazol	Cilostazol	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Finasteride	Finasteride	16	11
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Nitroglycerin	Nitroglycerin	15	13
Nystatin	Nystatin	15	11
Ondansetron Hcl	Ondansetron Hcl	15	14
Chlorthalidone	Chlorthalidone	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Baclofen	Baclofen	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Ibu	Ibuprofen	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error